0001179110-20-005044.txt : 20200422 0001179110-20-005044.hdr.sgml : 20200422 20200422160829 ACCESSION NUMBER: 0001179110-20-005044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200421 FILED AS OF DATE: 20200422 DATE AS OF CHANGE: 20200422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manning Anthony M. CENTRAL INDEX KEY: 0001716468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 20808042 MAIL ADDRESS: STREET 1: C/O PALATIN TECHNOLOGIES, INC. STREET 2: 4B CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2020-04-21 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001716468 Manning Anthony M. C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Common Stock 2020-04-21 4 S 0 1886 30.55 D 12758 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person December 14, 2018. This transaction was executed in multiple trades at prices ranging from $30.31 to $30.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ R. Mark Chamberlin as attorney in fact 2020-04-22